Publications

  1. Sokumbi O, Hodge DO, Ederaine SA, Alavi A, Alikhan A. Comorbid diseases of hidradenitis suppurativa: a 15-year population-based study in Olmsted County, Minnesota, USA. Int J Dermatol. 2022 Nov; 61 (11):1372-1379 Epub 2022 Apr 29
    View PubMed
  2. Rick J, Gould LJ, Marzano AV, Garg A, Chen D, Oakes DL, Dissemond J, Herfarth H, Friedman MA, Alavi A, Yamamoto T, Gerbens LAA, Thomas KS, Ortega-Loayza AG. The "Understanding Pyoderma Gangrenosum, Review and Assessment of Disease Effects (UPGRADE)" Project: a protocol for the development of the core outcome domain set for trials in pyoderma gangrenosum. Arch Dermatol Res. 2022 Oct 28 [Epub ahead of print]
    View PubMed
  3. Tzellos T, van Straalen KR, Kyrgidis A, Alavi A, Goldfarb N, Gulliver W, Jemec GBE, Lowes MA, Marzano AV, Prens EP, Sayed CJ, van der Zee HH, Zouboulis CC. Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2022 Oct 2 Epub 2022 Oct 02
    View PubMed
  4. Hanna N, Silverberg OM, Reaume M, Gladman D, Davis MDP, Piguet V, Alavi A. Incidence, prevalence, and predictors of inflammatory arthritis in patients with hidradenitis suppurativa: a systematic review and meta-analysis. Int J Dermatol. 2022 Sep; 61 (9):1069-1079 Epub 2021 Aug 25
    View PubMed
  5. Croitoru D, Nathanielsz N, Seigel K, Elsawi R, Sibbald C, Alavi A, Zipursky J, Piguet V. Clinical manifestations and treatment outcomes of pyoderma gangrenosum following rituximab exposure: A systematic review. J Am Acad Dermatol. 2022 Sep; 87 (3):655-656 Epub 2021 Dec 20
    View PubMed
  6. Rypka KJ, Fulk TS, Afsaneh A, Miller DD, Goldfarb NI. Improvement of Facial Discoid Dermatosis With Ustekinumab Treatment. JAMA Dermatol. 2022 Sep 1; 158 (9):1079-1080
    View PubMed
  7. Anand NC, Takaichi M, Johnson EF, Wetter DA, Davis MDP, Alavi A. Suggestions for a New Clinical Classification Approach to Panniculitis Based on a Mayo Clinic Experience of 207 Cases. Am J Clin Dermatol. 2022 Sep; 23 (5):739-746 Epub 2022 July 18
    View PubMed
  8. Mehta MM, Hanna N, Lowes MA, Alavi A. The incidence and risk of respiratory tract infections in patients using biologics for hidradenitis suppurativa: a systematic review and meta-analysis. Journal of Drugs in Dermatology. 2022 Aug; 21 (8):819-24
  9. Midgette B, Strunk A, Akilov O, Alavi A, Ardon C, Bechara FG, Cohen AD, Cohen S, Daveluy S, Del Marmol V, Delage M, Esmann S, Fisher S, Giamarellos-Bourboulis EJ, Glowaczewska A, Goldfarb N, Brant EG, Grimstad O, Guilbault S, Hamzavi I, Hughes R, Ingram JR, Jemec GBE, Ju Q, Kappe N, Kirby B, Kirby JS, Lowes MA, Matusiak L, Micha S, Micheletti R, Miller AP, Moseng D, Naik H, Nassif A, Nikolakis G, Paek SY, Pascual JC, Prens E, Resnik B, Riad H, Sayed C, Smith SD, Soliman Y, Szepietowski JC, Tan J, Thorlacius L, Tzellos T, van der Zee HH, Villumsen B, Wang L, Zouboulis C, Garg A. Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project. Br J Dermatol. 2022 Jul 30 Epub 2022 July 30
    View PubMed
  10. Deo N, Mastin M, Peters M, Wieland C, Alavi A. Multiple Nodules on the Bilateral Lower Extremities: Answer. Am J Dermatopathol. 2022 Jul 1; 44 (7):534
    View PubMed
  11. Anand N, Niezgoda J, Alavi A. 35 Years of Advances in Skin & Wound Care: Celebrating the Evolution of the Wound Care Team. Adv Skin Wound Care. 2022 Jul 1; 35 (7):360-362
    View PubMed
  12. Deo NN, Mastin MR, Peters MS, Wieland CN, Alavi A. Multiple Nodules on the Bilateral Lower Extremities: Challenge. Am J Dermatopathol. 2022 Jul 1; 44 (7):e69-e70
    View PubMed
  13. Yamanaka-Takaichi M, Ghanian S, Katzka DA, Torgerson RR, Alavi A. Candida Infection Associated with Anti-IL-17 Medication: A Systematic Analysis and Review of the Literature. Am J Clin Dermatol. 2022 Jul; 23 (4):469-480 Epub 2022 Apr 15
    View PubMed
  14. Rick JW, De DR, Shih T, Alavi A, Kirby JS, Naik HB, Frew JW, Sayed CJ, Hsiao JL, Shi VY. Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts. Skin Appendage Disord. 2022 Jul; 8 (4):287-290 Epub 2022 Jan 10
    View PubMed
  15. Gulliver W, Alavi A, Wiseman MC, Gooderham MJ, Rao J, Shayesteh Alam M, Papp KA, Desjardins O, Jean C. Real-World Moderate-to-Severe Hidradenitis Suppurativa: Decrease in Disease Burden With Adalimumab. J Cutan Med Surg. 2022 Jul-Aug; 26 (4):361-370 Epub 2022 Mar 24
    View PubMed
  16. Vance P, Wyles S, Alavi A. Paraneoplastic Pityriasis Rubra Pilaris Preceding Leukemia. Adv Skin Wound Care. 2022 Jun 1; 35 (6):1-4
    View PubMed
  17. Shavit E , Alavi A . Get it off your chest: a narrative review of breast ulcers. Advances in Skin & Wound Care. 2022 Jun; 35 (6):306-13
  18. Alavi A, Hamzavi I, Brown K, Santos LL, Zhu Z, Liu H, Howell MD, Kirby JS. Janus kinase 1 inhibitor INCB054707 for patients with moderate-to-severe hidradenitis suppurativa: results from two phase II studies. Br J Dermatol. 2022 May; 186 (5):803-813 Epub 2022 Mar 06
    View PubMed
  19. Sachdeva M, Kim P, Mufti A, Maliyar K, Sibbald C, Alavi A. Biologic Use in Pediatric Patients With Hidradenitis Suppurativa: A Systematic Review. J Cutan Med Surg. 2022 Mar-Apr; 26(2):176-180. Epub 2021 Sep 29.
    View PubMed
  20. Ghanian S, Yamanaka-Takaichi M, Naik HB, Alavi A. Medical Management of Hidradenitis Suppurativa with Non-Biologic Therapy: What's New? Am J Clin Dermatol. 2022 Mar; 23 (2):167-176 Epub 2022 Jan 06
    View PubMed
  21. Rick JW, Shih T, Alavi A, Hsiao J, Shi V, Deveade. Lifestyle Modifications and Complementary Treatments for Hidradenitis Suppurativa Dermatological Reviews. 2022.
  22. Lowes MA, Goldberg SR, Alavi A, Naik HB. Combining Medical and Surgical Management Strategies for Hidradenitis Suppurativa: Need for a Treat-to-Target Approach Dermatological Reviews. 2022.
  23. Kohn AH, Alavi A, Armstrong AW, Babalola F, Garg A, Gottlieb AB, Grilli L, Jemec GBE, Latella J, Marcus K, Merola JF, Ortega-Loayza AG, Siegel DM, Strand V, Tan JKL, Perez-Chada LM. International Dermatology Outcome Measures (IDEOM): Report from the 2020 Annual Meeting. Dermatology. 2022; 238 (3):430-437 Epub 2021 Sept 17
    View PubMed
  24. Sachdeva M, Lu JD, Croitoru D, Alavi A. Pyoderma Gangrenosum and Metabolic Comorbidities: A Systemic Review JCMS. 2022.
  25. Croitoru D, Nathanielsz N, Seigel K, Elsawi R, Sibbald C, Alavi A, Zipursky J, Piguet V. Treatment Outcomes for Pyoderma Gangrenosum on Rituximab Therapy: A Systemic Review JAAD. 2022.
  26. Gulliver W, Alavi A, Wiseman MC, Gooderham MJ, Rao J, Alam MS, Papp KA, Desjardins O, Jean C. Real-world effectiveness of adalimumab in patients with moderate-to-severe hidradenitis suppurativa: the 1-year SOLACE study. J Eur Acad Dermatol Venereol. 2021 Dec; 35 (12):2431-2439 Epub 2021 Aug 25
    View PubMed
  27. Alavi A, Baradaran S, Mathias SD, Colwell HH, Song M, Hamzavi IH, Han C. Development of a Patient-Reported Outcome Questionnaire to Assess Signs and Symptoms of Hidradenitis Suppurativa: The Hidradenitis Suppurativa Symptom Diary (HSSD). J Am Acad Dermatol. 2021 Nov 19 [Epub ahead of print]
    View PubMed
  28. Fletcher J, Posso-De Los Rios C, Jambrosic J, Alavi A. Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex: Is It a New Variant of Hidradenitis Suppurativa? J Cutan Med Surg. 2021 Nov-Dec; 25 (6):586-590 Epub 2021 Apr 28
    View PubMed
  29. Gotesman RD, Choi C, Alavi A. Hidradenitis suppurativa in East and Southeast Asian populations: a systematic review and meta-analysis. Int J Dermatol. 2021 Nov; 60 (11):e433-e439 Epub 2021 June 01
    View PubMed
  30. Tai F, Shah M, Pon K, Alavi A. Laser Resurfacing Monotherapy for the Treatment of Actinic Keratosis. J Cutan Med Surg. 2021 Nov-Dec; 25(6):634-642. Epub 2021 Jul 02.
    View PubMed
  31. Bechara FG, Podda M, Prens EP, Horvath B, Giamarellos-Bourboulis EJ, Alavi A, Szepietowski JC, Kirby J, Geng Z, Jean C, Jemec GBE, Zouboulis CC. Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa: The SHARPS Randomized Clinical Trial. JAMA Surg. 2021 Nov 1; 156 (11):1001-1009
    View PubMed
  32. Frew JW, Alavi A, Kirby JS. An Abscess Is Not a Descriptive Term but an Entity With a Universally Accepted Definition-A Clarification on Semantics-Reply. JAMA Dermatol 2021 Oct 1; 157 (10):1245-1246
    View PubMed
  33. Machado MO, Kang NC, Tai F, Sambhi RDS, Berk M, Carvalho AF, Chada LP, Merola JF, Piguet V, Alavi A. Measuring fatigue: a meta-review. Int J Dermatol. 2021 Sep; 60 (9):1053-1069 Epub 2020 Dec 10
    View PubMed
  34. McPhie ML, Fletcher J, Machado MO, Carvalho AF, Piguet V, Alavi A. A Systematic Review of Depression and Anxiety in Adults with Pyoderma Gangrenosum. Adv Skin Wound Care. 2021 Aug 1; 34 (8):432-436
    View PubMed
  35. Silverberg JI, Pinter A, Alavi A, Lynde C, Bouaziz JD, Wollenberg A, Murrell DF, Alpizar S, Laquer V, Chaouche K, Ahmad F, Armstrong JM, Piketty C. Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI >/= 16) analysis of randomized phase 2B study. J Eur Acad Dermatol Venereol. 2021 Jul; 35 (7):1562-1568 Epub 2021 Apr 01
    View PubMed
  36. Shavit E, Cecchini M, Limacher JJ, Walsh S, Wentworth A, Davis MDP, Alavi A. Superficial Granulomatous Pyoderma Gangrenosum Involving the Face: A Case Series of Five Patients and a Review of the Literature [Formula: see text]. J Cutan Med Surg. 2021 Jul-Aug; 25 (4):371-376 Epub 2021 Feb 05
    View PubMed
  37. Hines A, Alavi A, Davis MDP. Cutaneous Manifestations of Diabetes. Med Clin North Am. 2021 Jul; 105 (4):681-697
    View PubMed
  38. Abdalla T, Lytvyn Y, McDonald KA, Mufti A, Alavi A. Cannabinoids in Dermatologic Surgery Journal of the American Academy of Dermatology. 2021. Epub 2021 May 17.
  39. Frew JW, Lowes MA, Goldfarb N, Butt M, Piguet V, O'Brien E, Ingram J, Jemec GBE, Tan J, Zouboulis C, Alavi A, Kirby JS. Global Harmonization of Morphological Definitions in Hidradenitis Suppurativa for a Proposed Glossary. JAMA Dermatol. 2021 Apr 1; 157 (4):449-455
    View PubMed
  40. Sibbald RG, Elliott JA, Persaud-Jaimangal R, Goodman L, Armstrong DG, Harley C, Coelho S, Xi N, Evans R, Mayer DO, Zhao X, Heil J, Kotru B, Delmore B, LeBlanc K, Ayello EA, Smart H, Tariq G, Alavi A, Somayaji R. Wound Bed Preparation 2021. Adv Skin Wound Care. 2021 Apr 1; 34 (4):183-195
    View PubMed
  41. Lu JD, Milakovic M, Piguet V, Alavi A. Antidrug antibodies to tumour necrosis factor inhibitors in hidradenitis suppurativa: a systematic review. Br J Dermatol 2021 Mar; 184 (3):555-557 Epub 2021 Feb 08
    View PubMed
  42. Abdalla T, Lowes MA, Kaur N, Micheletti RG, Steinhart AH, Alavi A. Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-alpha Inhibitors? Am J Clin Dermatol. 2021 Mar; 22 (2):139-147
    View PubMed
  43. Price KN, Collier EK, Grogan T, Fernandez JM, Alhusayen R, Alavi A, Hamzavi IH, Lowes MA, Porter MJ, Hsiao JL, Shi VY. Physician perspectives on complementary and alternative medicine in hidradenitis suppurativa. Dermatol Ther. 2021 Mar; 34 (2):e14851 Epub 2021 Feb 20
    View PubMed
  44. Abdalla T, Mansour M, Bouazzi D, Lowes MA, Jemec GBE, Alavi A. Therapeutic Drug Monitoring in Patients with Suboptimal Response to Adalimumab for Hidradenitis Suppurativa: A Retrospective Case Series. Am J Clin Dermatol. 2021 Mar; 22(2):275-283. Epub 2020 Nov 26.
    View PubMed
  45. Alavi A, Goldenberg A, Jacob S, Shelley A, Kirsner R. Contact Dermatitis: An Important Consideration in Leg Ulcers International Journal of Women's Dermatology. 2021.
  46. Garg A, Malviya N, Strunk A, Wright S, Alavi A, Alhusayen R, Alikhan A, Daveluy SD, Delome I, Goldfarb N, Gulliver W, Hamzavi I, Jaleel T, Kimball A, Kirby J, Kirchhof MG, Lester J, Lev-Tov H, Lowes MA, Micheletti R, Orenstein L, Piguet V, Sayed C, Tan J, Naik HB. Comorbidity Screening in Hidradenitis Suppurativa: Evidence-Based Recommendations from the US and Canadian Hidradenitis Suppurativa Foundations J Am Acad Dermatol. 01/22/2021. Epub 2021 Jan 04.
  47. Alavi A, Archer J, Coutts P. Use of an advanced collagen matrix dressing on patients with complex chronic lower extremity ulcers: A case series. SAGE Open Med Case Rep. 2021; 9:2050313X211013684. Epub 2021 May 13.
    View PubMed
  48. Alavi A, Karvar M, Panayi A, Orgill DP, Ross K. Trends in The Management of Hidradenitis Suppurativa in the Middle East Region: A Systemic Review International Journal of Dermatology. 2020.
  49. Croitoru D, Naderi-Azad S, Sachdeva M, Piguet V, Alavi A. A Wound Care Specialist's Approach to Pyoderma Gangrenosum. Adv Wound Care (New Rochelle). 2020 Dec; 9(12):686-694. Epub 2020 Jun 16.
    View PubMed
  50. Alavi A, Shi V, Hsiao J, Collier E, Seivright JR, Price K, Grogan TR, Fernandez JA. Provider Perspectives on the Management of Hidradenitis Suppurativa in Pregnancy - a Survey Study International Journal of Women's Dermatology. 2020.
  51. Pikety A, Silverberg J, Pinter A, Alavi A, Bouaziz JD. Nemolizumab is Associated with a Rapid Improvement in Atopic Dermatitis Signs and Symptoms: Subpopulation (EASI =16) Analysis of Phase 2B Study Journal of the European Academy of Dermatology and Venereology. 2020.
  52. Sachdeva M, Shah M, Alavi A. Race-Specific Prevalence of Hidradenitis Suppurativa. J Cutan Med Surg. 2020 Nov 11; 1203475420972348 [Epub ahead of print]
    View PubMed
  53. Lu JD, Hobbs MM, Huang WW, Ortega-Loayza AG, Alavi A. Identification and evaluation of outcome measurement instruments in pyoderma gangrenosum: a systematic review. Br J Dermatol. 2020 Nov; 183(5):821-828. Epub 2020 May 07.
    View PubMed
  54. Lu JD, Milakovic M, Ortega-Loayza AG, Marzano AV, Alavi A. Pyoderma gangrenosum: proposed pathogenesis and current use of biologics with an emphasis on complement C5a inhibitor IFX-1. Expert Opin Investig Drugs. 2020 Nov; 29 (11):1179-1185 Epub 2020 Sept 29
    View PubMed
  55. Shavit E, Marzano AV, Alavi A. Ulcerative versus non-ulcerative panniculitis: is it time for a novel clinical approach to panniculitis? Int J Dermatol. 2020 Oct 11 [Epub ahead of print]
    View PubMed
  56. Goldfarb N, Lowes MA, Butt M, King T, Alavi A, Kirby JS. Hidradenitis Suppurativa Area and Severity Index Revised (HASI-R): psychometric property assessment. Br J Dermatol. 2020 Sep 23 Epub 2020 Sept 23
    View PubMed
  57. Frew JW, Marzano AV, Wolk K, Join-Lambert O, Alavi A, Lowes MA, Piguet V. A Systematic Review of Promising Therapeutic Targets in Hidradenitis Suppurativa: A Critical Evaluation of Mechanistic and Clinical Relevance. J Invest Dermatol. 2020 Sep 9 Epub 2020 Sept 09
    View PubMed
  58. Narla S, Azzam M, Townsend S, Vellaichamy G, Marzano AV, Alavi A, Lowes MA, Hamzavi IH. Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils. Br J Dermatol. 2020 Sep 7 Epub 2020 Sept 07
    View PubMed
  59. Shah M, Sachdeva M, Alavi A. Work impairment in a woman with severe hidradenitis suppurativa after delayed diagnosis: A call for action. Int J Womens Dermatol. 2020 Sep; 6 (4):327-328 Epub 2020 May 31
    View PubMed
  60. Shavit E, Alavi A, George R. Inframammary Hidradenitis Suppurativa: An optimal surgical approach to a challenging region. Breast J. 2020 Aug 05. [Epub ahead of print]
    View PubMed
  61. Alavi A, Shah M, Kang NC. Inflamed, Purulent Axillary Nodules. Am Fam Physician. 2020 Jul 15; 102(2):111-112.
    View PubMed
  62. Price KN, Alavi A, Hsiao JL, Shi VY. Gender Minority Patients in Dermatology Clinical Trials International Journal of Women's Dermatology. 06/04/2020; 438-439.
  63. Narla S, Price KN, Sachdeva M, Shah M, Shi V, Hamzavi I, Alavi A, Lowes MA. Proceeding report of the fourth Symposium on Hidradenitis Suppurativa Advances (SHSA) 2019. J Am Acad Dermatol. 2020 Jun 01. [Epub ahead of print]
    View PubMed
  64. Bezerra AP, Machado MO, Maes M, Marazziti D, Nunes-Neto PR, Solmi M, Firth J, Husain MI, Brunoni AR, Kurdyak P, Smith L, Alavi A, Piguet V, Carvalho AF. Trichotillomania-psychopathological correlates and associations with health-related quality of life in a large sample. CNS Spectr. 2020 Apr 08; 1-8. [Epub ahead of print]
    View PubMed
  65. Ghias MH, Hyde MJ, Tomalin LE, Morgan BP, Alavi A, Lowes MA, Piguet V. Role of the Complement Pathway in Inflammatory Skin Diseases: A Focus on Hidradenitis Suppurativa. J Invest Dermatol. 2020 Mar; 140(3):531-536.e1. Epub 2019 Dec 20.
    View PubMed
  66. Shavit E, Pawliwec A, Alavi A, George R. The surgeon’s perspective: a retrospective study of wide local excisions taken to healthy subcutaneous fat in the management of advanced hidradenitis suppurativa Can J Surg. 2020 Feb 28; 63(2):E94-E99.
    View PubMed
  67. Mufti A, Maliyar K, Syed M, Pagnoux C, Alavi A. Approaches to Microthrombotic Wounds: A Review of Pathogenesis and Clinical Features. Adv Skin Wound Care. 2020 Feb; 33(2):68-75.
    View PubMed
  68. Garg A, Neuren E, Cha D, Kirby JS, Ingram JR, Jemec GBE, Esmann S, Thorlacius L, Villumsen B, Marmol VD, Nassif A, Delage M, Tzellos T, Moseng D, Grimstad Ø, Naik H, Micheletti R, Guilbault S, Miller AP, Hamzavi I, van der Zee H, Prens E, Kappe N, Ardon C, Kirby B, Hughes R, Zouboulis CC, Nikolakis G, Bechara FG, Matusiak L, Szepietowski J, Glowaczewska A, Smith SD, Goldfarb N, Daveluy S, Avgoustou C, Giamarellos-Bourboulis E, Cohen S, Soliman Y, Brant EG, Akilov O, Sayed C, Tan J, Alavi A, Lowes MA, Pascual JC, Riad H, Fisher S, Cohen A, Paek SY, Resnik B, Ju Q, Wang L, Strunk A. Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project. J Am Acad Dermatol. 2020 Feb; 82(2):366-376. Epub 2019 Jul 03.
    View PubMed
  69. Price KN, Thompson AM, Rizvi O, Hendricks AJ, Alavi A, Hsiao JL, Shi VY. Complementary and Alternative Medicine Use in Patients With Hidradenitis Suppurativa. JAMA Dermatol. 2020 Jan 29 [Epub ahead of print]
    View PubMed
  70. Amir Ali A, Seng EK, Alavi A, Lowes MA. Exploring changes in placebo treatment arms in hidradenitis suppurativa randomized clinical trials: A systematic review. J Am Acad Dermatol. 2020 Jan; 82(1):45-53. Epub 2019 May 29.
    View PubMed
  71. Tai F, Jakubovic H, Alabdulrazzaq S, Alavi A. A case of sporotrichosis infection mimicking pyoderma gangrenosum and the role of tissue culture in diagnosis: A case report. SAGE Open Med Case Rep. 2020; 8:2050313X20919600. Epub 2020 May 18.
    View PubMed
  72. Alavi A. Use of an Advanced Collagen Matrix Dressing on Patients with Complex Chronic Lower Extremity Ulcers: A Case Series SAGE Open Medical Case Reports. 2020.
  73. Benhadou F, Van der Zee HH, Pascual JC, Rigopoulos D, Katoulis A, Liakou AI, Daxhelet M, Romanelli M, Iannone M, Kinyo A, Nikolakis G, Zouboulis CC, Dessinioti C, Zisimou C, Antoniou C, Alavi A, Mintoff D, Aquilina S, Matusiak L, Szepietowski JC, Sinclair R, Husein-ElAhmed H, von Laffert M, Revuz J, Danby B, Puig L, Theut Riis P, Jemec GBE, van Straalen K, Wigny KMGJ, Del Marmol V, Guillem P. Pilonidal sinus disease: an intergluteal localization of hidradenitis suppurativa/acne inversa: a cross-sectional study among 2465 patients. Br J Dermatol. 2019 Dec; 181 (6):1198-1206 Epub 2019 May 06
    View PubMed
  74. Shavit E, Alkallabi M, Alavi A. Scalp ulcers - differential diagnoses that should be sought! Int J Dermatol. 2019 Nov; 58(11):1283-1292. Epub 2019 Jul 02.
    View PubMed
  75. Maliyar K, Mufti A, Syed M, Selk A, Dutil M, Bunce PE, Alavi A. Genital Ulcer Disease: A Review of Pathogenesis and Clinical Features. J Cutan Med Surg. 2019 Nov/Dec; 23(6):624-634. Epub 2019 Jun 28.
    View PubMed
  76. Rajabi-Estarabadi A, Kayssi A, Alavi A, Kirsner RS. Vascular Tests for Dermatologists. Am J Clin Dermatol. 2019 Oct; 20(5):657-667.
    View PubMed
  77. Alavi A, Piguet V. Genotype-phenotype correlation in inherited hidradenitis suppurativa: one step forward, one step back Br J Dermatol. 2019 Sep; 181(3):443-444.
  78. Huang CM, Lowes MA, Cserti C, Alavi A. Hemoglobin Levels and Serum C-Reactive Protein in Patients With Moderate to Severe Hidradenitis Suppurativa. J Cutan Med Surg. 2019 Sep/Oct; 23(5):501-506. Epub 2019 Jun 28.
    View PubMed
  79. Jfri AH, O'Brien EA, Litvinov IV, Alavi A, Netchiporouk E. Hidradenitis Suppurativa: Comprehensive Review of Predisposing Genetic Mutations and Changes. J Cutan Med Surg. 2019 Sep/Oct; 23(5):519-527. Epub 2019 Jun 06.
    View PubMed
  80. Byrd AS, Dina Y, Okoh UJ, Quartey QQ, Carmona-Rivera C, Williams DW, Kerns ML, Miller RJ, Petukhova L, Naik HB, Barnes LA, Shipman WD, Caffrey JA, Sacks JM, Milner SM, Aliu O, Broderick KP, Kim D, Liu H, Dillen CA, Ahn R, Frew JW, Kaplan MJ, Kang S, Garza LA, Miller LS, Alavi A, Lowes MA, Okoye GA. Specimen Collection for Translational Studies in Hidradenitis Suppurativa. Sci Rep. 2019 Aug 21; 9 (1):12207
    View PubMed
  81. Jfri A, O'Brien E, Alavi A, Goldberg SR. Association of hidradenitis suppurativa and keloid formation: A therapeutic challenge. JAAD Case Rep. 2019 Aug; 5 (8):675-678 Epub 2019 Aug 02
    View PubMed
  82. Posso-De Los Rios CJ, Sarfo A, Ghias M, Alhusayen R, Hamzavi I, Lowes MA, Alavi A. Proceeding report of the third symposium on Hidradenitis Suppurativa advances (SHSA) 2018. Exp Dermatol. 2019 Jul; 28(7):769-775. Epub 2019 Apr 29.
    View PubMed
  83. Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, Crowell K, Eisen DB, Gottlieb AB, Hamzavi I, Hazen PG, Jaleel T, Kimball AB, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019 Jul; 81(1):76-90. Epub 2019 Mar 11.
    View PubMed
  84. Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, Crowell K, Eisen DB, Gottlieb AB, Hamzavi I, Hazen PG, Jaleel T, Kimball AB, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019 Jul; 81(1):91-101. Epub 2019 Mar 11.
    View PubMed
  85. Naik HB, Paul M, Cohen SR, Alavi A, Suàrez-Fariñas M, Lowes MA. Distribution of Self-reported Hidradenitis Suppurativa Age at Onset. JAMA Dermatol. 2019 Jun 05. [Epub ahead of print]
    View PubMed
  86. Machado MO, Stergiopoulos V, Maes M, Kurdyak PA, Lin PY, Wang LJ, Shyu YC, Firth J, Koyanagi A, Solmi M, Alavi A, Piguet V, Carvalho AF. Depression and Anxiety in Adults With Hidradenitis Suppurativa: A Systematic Review and Meta-analysis. JAMA Dermatol. 2019 Jun 5 Epub 2019 June 05
    View PubMed
  87. Percival SL, Mayer D, Kirsner RS, Schultz G, Weir D, Roy S, Alavi A, Romanelli M. Surfactants: Role in biofilm management and cellular behaviour. Int Wound J. 2019 Jun; 16(3):753-760. Epub 2019 Mar 18.
    View PubMed
  88. Shavit E, Alavi A, Bechara FG, Bennett RG, Bourcier M, Cibotti R, Daveluy S, Frew JW, Garg A, Hamzavi I, Hoffman LK, Hsaio J, Kirby JS, Lev-Tov H, Martinez E, Micheletti R, Naik HB, Nassif A, Nicholson C, Parks-Miller A, Patel Z, Piguet V, Ramesh M, Resnik B, Sayed C, Schultz G, Siddiqui A, Tan J, Wortsman X, Lowes MA. Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017. Exp Dermatol. 2019 Jan; 28(1):94-103.
    View PubMed
  89. Naik HB, Nassif A, Ramesh MS, Schultz G, Piguet V, Alavi A, Lowes MA. Are Bacteria Infectious Pathogens in Hidradenitis Suppurativa? Debate at the Symposium for Hidradenitis Suppurativa Advances Meeting, November 2017. J Invest Dermatol. 2019 Jan; 139(1):13-16. Epub 2018 Nov 08.
    View PubMed
  90. McDonald KA, Shelley AJ, Pierscianowski T, Alavi A. A 2017 update: Challenging the cosmetic procedural delay following oral isotretinoin therapy. J Cosmet Laser Ther. 2019; 21(1):58-60. Epub 2018 Feb 28.
    View PubMed
  91. Fletcher J, Alhusayen R, Alavi A. Recent advances in managing and understanding pyoderma gangrenosum. F1000Res. 2019; 8. Epub 2019 Dec 12.
    View PubMed
  92. Alavi A, Shavit E, Archer J, Pagnoux C. Hidradenitis suppurativa and vasculitis: A case series and literature review of a rare association. SAGE Open Med Case Rep. 2019; 7:2050313X19882852. Epub 2019 Oct 21.
    View PubMed
  93. Sandhu VK, Alavi A. The role of anti-tumour necrosis factor in wound healing: A case report of refractory ulcerated necrobiosis lipoidica treated with adalimumab and review of the literature. SAGE Open Med Case Rep. 2019; 7:2050313X19881594. Epub 2019 Oct 18.
    View PubMed
  94. Shavit E, Wollina U, Alavi A. Lipoedema is not lymphoedema: A review of current literature. Int Wound J. 2018 Dec; 15(6):921-928. Epub 2018 Jun 29.
    View PubMed
  95. Shavit E, Alavi A, Sibbald RG. Vasculitis-What Do We Have to Know? A Review of Literature. Int J Low Extrem Wounds. 2018 Dec; 17(4):218-226. Epub 2018 Dec 03.
    View PubMed
  96. Micieli R, Alavi A. Lymphedema in patients with hidradenitis suppurativa: a systematic review of published literature. Int J Dermatol. 2018 Dec; 57(12):1471-1480. Epub 2018 Aug 13.
    View PubMed
  97. Micieli R, Alavi A. Eruptive lentiginosis in resolving psoriatic plaques. JAAD Case Rep. 2018 Oct; 4(9):924-929. Epub 2018 Oct 10.
    View PubMed
  98. Mak J, Al Habeeb A, Al Kalabi M, Alavi A. Pyoderma Gangranosum-Like Blastomycosis. J Cutan Med Surg. 2018 Sep/Oct; 22(5):519-521. Epub 2018 Feb 28.
    View PubMed
  99. Almutairi D, Sheasgreen C, Weizman A, Alavi A. Generalized Pustular Psoriasis Induced by Infliximab in a Patient With Inflammatory Bowel Disease. J Cutan Med Surg. 2018 Sep/Oct; 22(5):507-510. Epub 2018 Feb 27.
    View PubMed
  100. Wang JY, Ighani A, Ayala AP, Akita S, Lara-Corrales I, Alavi A. Medical, Surgical, and Wound Care Management of Ulcerated Infantile Hemangiomas: A Systematic Review [Formula: see text]. J Cutan Med Surg. 2018 Sep/Oct; 22(5):495-504. Epub 2018 Apr 19.
    View PubMed
  101. Alavi A, Sibbald RG, Kirsner RS. Optimal hidradenitis suppurativa topical treatment and wound care management: a revised algorithm. J Dermatolog Treat. 2018 Jun; 29(4):383-384. Epub 2017 Oct 16.
    View PubMed
  102. Alavi A, Farzanfar D, Rogalska T, Lowes MA, Chavoshi S. Quality of life and sexual health in patients with hidradenitis suppurativa. Int J Womens Dermatol. 2018 Jun; 4(2):74-79. Epub 2018 Feb 01.
    View PubMed
  103. Mehdizadeh A, Rosella L, Alavi A, Sibbald G, Farzanfar D, Hazrati A, Vernich L, Laporte A, Hu H, Bashash M. A Canadian Population-Based Cohort to the Study Cost and Burden of Surgically Resected Hidradenitis Suppurativa. J Cutan Med Surg. 2018 May/Jun; 22 (3):312-317 Epub 2018 Mar 11
    View PubMed
  104. Almutairi D, LeBlanc K, Alavi A. Peristomal skin complications: what dermatologists need to know. Int J Dermatol. 2018 Mar; 57(3):257-264. Epub 2017 Aug 22.
    View PubMed
  105. Alavi A, Farzanfar D, Lee RK, Almutairi D. The Contribution of Malodour in Quality of Life of Patients With Hidradenitis Suppurativa. J Cutan Med Surg. 2018 Mar/Apr; 22(2):166-174. Epub 2017 Dec 12.
    View PubMed
  106. Wang JY, French LE, Shear NH, Amiri A, Alavi A. Drug-Induced Pyoderma Gangrenosum: A Review. Am J Clin Dermatol. 2018 Feb; 19(1):67-77.
    View PubMed
  107. Micieli R, Alavi A. Treatment for Livedoid Vasculopathy: A Systematic Review. JAMA Dermatol. 2018 Feb 01; 154(2):193-202.
    View PubMed
  108. Shavit E, Alavi A, Limacher JJ, Sibbald RG. Angiosarcoma complicating lower leg elephantiasis in a male patient: An unusual clinical complication, case report and literature review. SAGE Open Med Case Rep. 2018; 6:2050313X18796343. Epub 2018 Oct 30.
    View PubMed
  109. Hoffman LK, Tomalin LE, Schultz G, Howell MD, Anandasabapathy N, Alavi A, Suárez-Fariñas M, Lowes MA. Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature. PLoS One. 2018; 13(9):e0203672. Epub 2018 Sep 28.
    View PubMed
  110. Mehdizadeh A, Alavi A, Alhusayen R, Bauer B, Bechara FG, Bourcier M, Brassard A, Djamei V, Dutz J, George R, Ghias M, Gooderham M, Hamzavi I, Hoffman LK, Hou A, Hu H, Kimball AB, Kirchhof M, Kryzskaya D, Liy Wong MDC, Lowes MA, Lynde CW, McLellen C, Prens E, Prens L, Rogalska T, Sibbald RG, Sisic M, Tan MG, Wong DD. Proceeding report of the Symposium on Hidradenitis Suppurativa Advances (SHSA). Exp Dermatol. 2018 Jan; 27(1):104-112. Epub 2017 Nov 15.
    View PubMed
  111. Farzanfar D, Dowlati Y, French LE, Lowes MA, Alavi A. Inflammation: A Contributor to Depressive Comorbidity in Inflammatory Skin Disease. Skin Pharmacol Physiol. 2018; 31(5):246-251. Epub 2018 Jun 28.
    View PubMed
  112. Shavit E, Alavi A, Sibbald RG. Pyoderma Gangrenosum: A Critical Appraisal. Adv Skin Wound Care. 2017 Dec; 30(12):534-542.
    View PubMed
  113. Mistry BD, Alavi A, Ali S, Mistry N. A systematic review of the relationship between glycemic control and necrobiosis lipoidica diabeticorum in patients with diabetes mellitus. Int J Dermatol. 2017 Dec; 56(12):1319-1327. Epub 2017 Jun 26.
    View PubMed
  114. Alavi A, Lynde C, Alhusayen R, Bourcier M, Delorme I, George R, Gooderham M, Gulliver W, Kalia S, Marcoux D, Poulin Y. Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document. J Cutan Med Surg. 2017 Nov/Dec; 21(6):513-524. Epub 2017 Jun 22.
    View PubMed
  115. McDonald KA, Shelley AJ, Alavi A. A Systematic Review on Oral Isotretinoin Therapy and Clinically Observable Wound Healing in Acne Patients. J Cutan Med Surg. 2017 Jul/Aug; 21 (4):325-333 Epub 2017 Mar 31
    View PubMed
  116. Alavi A, French LE, Davis MD, Brassard A, Kirsner RS. Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment. Am J Clin Dermatol. 2017 Jun; 18(3):355-372.
    View PubMed
  117. Antia C, Alavi A, Alikhan A. Topical management and wound care approaches for hidradenitis suppurativa. Semin Cutan Med Surg. 2017 Jun; 36(2):58-61.
    View PubMed
  118. Hoffman LK, Ghias MH, Garg A, Hamzavi IH, Alavi A, Lowes MA. Major gaps in understanding and treatment of hidradenitis suppurativa. Semin Cutan Med Surg. 2017 Jun; 36(2):86-92.
    View PubMed
  119. Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M, SOLO 1 and SOLO 2 Investigators. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. N Engl J Med. 2016 Dec 15; 375 (24):2335-2348 Epub 2016 Sept 30
    View PubMed
  120. Yang GK, Cao S, Kayssi A, Dueck AD, Alavi A. Critical Evaluation of Delayed Healing of Venous Leg Ulcers: A Retrospective Analysis in Canadian Patients. Am J Clin Dermatol. 2016 Oct; 17(5):539-544.
    View PubMed
  121. Alavi A. Discussion: What Heals Hidradenitis Suppurativa: Surgery, Immunosuppression, or Both? Plast Reconstr Surg 2016 Sep; 138 (3 Suppl):230S-231S
    View PubMed
  122. Alavi A, Sibbald RG, Ladizinski B, Saraiya A, Lee KC, Skotnicki-Grant S, Maibach H. Wound-Related Allergic/Irritant Contact Dermatitis. Adv Skin Wound Care. 2016 Jun; 29(6):278-86.
    View PubMed
  123. Singh M, Alavi A, Wong R, Akita S. Radiodermatitis: A Review of Our Current Understanding. Am J Clin Dermatol. 2016 Jun; 17(3):277-92.
    View PubMed
  124. Alavi A, Sibbald RG, Phillips TJ, Miller OF, Margolis DJ, Marston W, Woo K, Romanelli M, Kirsner RS. What's new: Management of venous leg ulcers: Treating venous leg ulcers. J Am Acad Dermatol. 2016 Apr; 74(4):643-64; quiz 665-6.
    View PubMed
  125. Alavi A, Sibbald RG, Phillips TJ, Miller OF, Margolis DJ, Marston W, Woo K, Romanelli M, Kirsner RS. What's new: Management of venous leg ulcers: Approach to venous leg ulcers. J Am Acad Dermatol. 2016 Apr; 74(4):627-40; quiz 641-2.
    View PubMed
  126. Ghasemi F, Anooshirvani N, Sibbald RG, Alavi A. The Point Prevalence of Malignancy in a Wound Clinic. Int J Low Extrem Wounds. 2016 Mar; 15(1):58-62.
    View PubMed
  127. Criado PR, Alavi A, Valente NY, Sotto MN. Amantadine-Induced Livedo Racemosa. Int J Low Extrem Wounds. 2016 Mar; 15(1):78-81. Epub 2015 Sep 03.
    View PubMed
  128. Alavi A, Cohen AD, Gulliver W, Brassard A, Danby WB, Zouboulis CC. CHSF / HSF / EHSF joint pre-WCD Hidradenitis Suppurativa Symposium, Vancouver, Canada, June 6, 2015. Exp Dermatol. 2016 Feb; 25 Suppl 1:1-9.
    View PubMed
  129. Mufti A, Al-Mohammedi F, Alavi A. An unusual presentation of Vilanova disease (erythema nodosum migrans) with superficial histologic changes. JAAD Case Rep. 2016 Jan; 2(1):41-3. Epub 2016 Jan 29.
    View PubMed
  130. Kim WB, Sibbald RG, Hu H, Bashash M, Anooshirvani N, Coutts P, Alavi A. Clinical Features and Patient Outcomes of Hidradenitis Suppurativa: A Cross-Sectional Retrospective Study. J Cutan Med Surg. 2016 Jan; 20(1):52-7. Epub 2015 Aug 28.
    View PubMed
  131. Alavi A, Sibbald RG, Nabavizadeh R, Valaei F, Coutts P, Mayer D. Audible handheld Doppler ultrasound determines reliable and inexpensive exclusion of significant peripheral arterial disease. Vascular. 2015 Dec; 23(6):622-9. Epub 2015 Jan 27.
    View PubMed
  132. Alavi A, Kirsner RS. Local wound care and topical management of hidradenitis suppurativa. J Am Acad Dermatol. 2015 Nov; 73(5 Suppl 1):S55-61.
    View PubMed
  133. Mehdizadeh A, Hazen PG, Bechara FG, Zwingerman N, Moazenzadeh M, Bashash M, Sibbald RG, Alavi A. Recurrence of hidradenitis suppurativa after surgical management: A systematic review and meta-analysis. J Am Acad Dermatol. 2015 Nov; 73(5 Suppl 1):S70-7.
    View PubMed
  134. Okhovat JP, Alavi A. Lipedema: A Review of the Literature. Int J Low Extrem Wounds. 2015 Sep; 14(3):262-7. Epub 2014 Oct 17.
    View PubMed
  135. Wang SC, Wang SC, Alavi A, Alhusayen R, Bashash M, Sibbald RG. Hidradenitis Suppurativa: A Frequently Missed Diagnosis, Part 2: Treatment Options. Adv Skin Wound Care. 2015 Aug; 28 (8):372-80; quiz 381-2
    View PubMed
  136. Wang SC, Wang SC, Sibbald RG, Alhusayen R, Bashash M, Alavi A. Hidradenitis Suppurativa: A Frequently Missed Diagnosis, Part 1: A Review of Pathogenesis, Associations, and Clinical Features. Adv Skin Wound Care. 2015 Jul; 28(7):325-32; quiz 333-4.
    View PubMed
  137. Criado PR, de Souza EspinelI DP, Valentef NS, Alavi A, Kirsner RS. Livedoid vasculopathy and high levels of lipoprotein (a): response to danazol. Dermatol Ther. 2015 Jul-Aug; 28(4):248-53. Epub 2015 Mar 30.
    View PubMed
  138. Sibbald C, Reid S, Alavi A. Necrobiosis Lipoidica. Dermatol Clin. 2015 Jul; 33(3):343-60.
    View PubMed
  139. Criado PR, Grizzo Peres Martins AC, Gaviolli CF, Alavi A. Propylthiouracil-Induced Vasculitis With Antineutrophil Cytoplasmic Antibody. Int J Low Extrem Wounds. 2015 Jun; 14(2):187-91. Epub 2014 Sep 25.
    View PubMed
  140. Kim WB, Alavi A, Pope E, Walsh S. Epidermolysis Bullosa Pruriginosa: Case Series and Review of the Literature. Int J Low Extrem Wounds. 2015 Jun; 14(2):196-9. Epub 2015 Feb 17.
    View PubMed
  141. Mistry N, Gupta A, Alavi A, Sibbald RG. A review of the diagnosis and management of erythroderma (generalized red skin). Adv Skin Wound Care. 2015 May; 28(5):228-36; quiz 237-8.
    View PubMed
  142. Kim WB, Alavi A, Walsh S, Kim S, Pope E. Epidermolysis bullosa pruriginosa: a systematic review exploring genotype-phenotype correlation. Am J Clin Dermatol. 2015 Apr; 16(2):81-7.
    View PubMed
  143. Alavi A, Anooshirvani N, Kim WB, Coutts P, Sibbald RG. Quality-of-life impairment in patients with hidradenitis suppurativa: a Canadian study. Am J Clin Dermatol. 2015 Feb; 16(1):61-5.
    View PubMed
  144. Alavi A, Hafner J, Dutz JP, Mayer D, Sibbald RG, Criado PR, Senet P, Callen JP, Phillips TJ, Romanelli M, Kirsner RS. Atrophie blanche: is it associated with venous disease or livedoid vasculopathy? Adv Skin Wound Care. 2014 Nov; 27(11):518-24; quiz 525-6.
    View PubMed
  145. Bader MS, Alavi A. Management of hospitalized patients with diabetic foot infections. Hosp Pract (1995). 2014 Oct; 42(4):111-25.
    View PubMed
  146. Alavi A, Sajic D, Cerci FB, Ghazarian D, Rosenbach M, Jorizzo J. Neutrophilic dermatoses: an update. Am J Clin Dermatol. 2014 Oct; 15(5):413-23.
    View PubMed
  147. Ladizinski B, Alavi A, Jambrosic J, Mistry N, Sibbald RG. Cancers mimicking fungal infections. Adv Skin Wound Care. 2014 Jul; 27(7):301-9.
    View PubMed
  148. Criado PR, Alavi A, Kirsner RS. Elevated Levels of Coagulation Factor VIII in Patients With Venous Leg Ulcers. Int J Low Extrem Wounds. 2014 Jun; 13(2):130-134. Epub 2014 May 25.
    View PubMed
  149. Kim WB, Mistry N, Alavi A, Sibbald C, Sibbald RG. Pretibial Myxedema: Case Presentation and Review of Treatment Options. Int J Low Extrem Wounds. 2014 Jun; 13(2):152-154. Epub 2014 May 07.
    View PubMed
  150. Alavi A, Sibbald RG, Mayer D, Goodman L, Botros M, Armstrong DG, Woo K, Boeni T, Ayello EA, Kirsner RS. Diabetic foot ulcers: Part II. Management. J Am Acad Dermatol. 2014 Jan; 70(1):21.e1-24; quiz 45-6.
    View PubMed
  151. Alavi A, Sibbald RG, Mayer D, Goodman L, Botros M, Armstrong DG, Woo K, Boeni T, Ayello EA, Kirsner RS. Diabetic foot ulcers: Part I. Pathophysiology and prevention. J Am Acad Dermatol. 2014 Jan; 70(1):1.e1-18; quiz 19-20.
    View PubMed
  152. Alavi A, Hafner J, Dutz JP, Mayer D, Sibbald RG, Criado PR, Senet P, Callen JP, Phillips TJ, Romanelli M, Kirsner RS. Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach. J Am Acad Dermatol. 2013 Dec; 69(6):1033-1042.e1. Epub 2013 Sep 09.
    View PubMed
  153. Criado PR, Alavi A, Halpern I, Sotto MN, Kirsner RS. Unilateral livedoid vasculopathy associated with involutional phase of cutaneous infantile hemangioma: the connection to coagulation disorders. Int J Low Extrem Wounds. 2013 Dec; 12(4):306-9. Epub 2013 Sep 16.
    View PubMed
  154. Woo KY, Botros M, Kuhnke J, Evans R, Alavi A. Best practices for the management of foot ulcers in people with diabetes. Adv Skin Wound Care. 2013 Nov; 26(11):512-24; quiz 225-6.
    View PubMed
  155. Reid SD, Ladizinski B, Lee K, Baibergenova A, Alavi A. Update on necrobiosis lipoidica: a review of etiology, diagnosis, and treatment options. J Am Acad Dermatol. 2013 Nov; 69(5):783-791. Epub 2013 Aug 19.
    View PubMed
  156. Woo KY, Alavi A, Evans R, Despatis M, Allen J. New advances in compression therapy for venous leg ulcers. Surg Technol Int. 2013 Sep; 23:61-8.
    View PubMed
  157. Ladizinski B, Lee KC, Wilmer E, Alavi A, Mistry N, Sibbald RG. A review of the clinical variants and the management of psoriasis. Adv Skin Wound Care. 2013 Jun; 26(6):271-84; quiz 285-6.
    View PubMed
  158. Ghiasi N, Alavi A, Coutts PM, Ghazarian D, Sibbald RG. Necrobiotic xanthogranuloma as an unusual cause of refractive chronic bilateral leg ulceration. Int J Low Extrem Wounds. 2012 Dec; 11(4):293-5.
    View PubMed
  159. Alavi A, Mayer D, Hafner J, Sibbald RG. Martorell hypertensive ischemic leg ulcer: an underdiagnosed Entity©. Adv Skin Wound Care. 2012 Dec; 25(12):563-72; quiz 573-4.
    View PubMed
  160. Alavi A, Lowe J, Walsh S, Juurlink D, Mortaz-Hedjri S, Shear NH. Corticosteroid-induced hyperglycemia is increased 10-fold in patients with pemphigus. Int J Dermatol. 2012 Oct; 51(10):1248-52.
    View PubMed
  161. Sibbald RG, Ayello EA, Alavi A, Ostrow B, Lowe J, Botros M, Goodman L, Woo K, Smart H. Screening for the high-risk diabetic foot: a 60-second tool (2012). Adv Skin Wound Care. 2012 Oct; 25(10):465-76; quiz 477-8.
    View PubMed
  162. Ladizinski B, Bazakas A, Mistry N, Alavi A, Sibbald RG, Salcido R. Sickle cell disease and leg ulcers. Adv Skin Wound Care. 2012 Sep; 25(9):420-8.
    View PubMed
  163. Alavi A, Skotnicki S, Sussman G, Sibbald RG. Diagnosis and treatment of hand dermatitis. Adv Skin Wound Care. 2012 Aug; 25(8):371-80; quiz 381-2.
    View PubMed
  164. Sanjari M, Safari S, Shokoohi M, Safizade H, Rashidinezhad H, Mashrouteh M, Alavi A. A cross-sectional study in Kerman, Iran, on the effect of diabetic foot ulcer on health-related quality of life. Int J Low Extrem Wounds. 2011 Dec; 10(4):200-6.
    View PubMed
  165. Alavi A, Niakosari F, Sibbald RG. When and how to perform a biopsy on a chronic wound. Adv Skin Wound Care. 2010 Mar; 23(3):132-40; quiz 141-2.
    View PubMed
  166. Alavi A, Sanjari M, Haghdoost A, Sibbald RG. Common foot examination features of 247 Iranian patients with diabetes. Int Wound J. 2009 Apr; 6(2):117-22.
    View PubMed
  167. Smart V, Alavi A, Coutts P, Fierheller M, Coelho S, Linn Holness D, Sibbald RG. Contact allergens in persons with leg ulcers: a Canadian study in contact sensitization. Int J Low Extrem Wounds. 2008 Sep; 7(3):120-5.
    View PubMed
  168. Alavi A, Woo K, Sibbald RG. Common nail disorders and fungal infections. Adv Skin Wound Care. 2007 Jun; 20(6):346-57; quiz 357-9.
    View PubMed
  169. Alavi A. Wound care challenges faced in iran. Adv Skin Wound Care. 2007 Jan; 20(1):27-8.
    View PubMed
  170. Esfandiarpour I, Alavi A. Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis. Int J Dermatol. 2002 Aug; 41(8):521-4.
    View PubMed